Chlamydia pneumoniae -Induced Macrophage Foam Cell Formation Is Mediated by Toll-Like Receptor 2
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Chlamydia pneumoniae induces macrophage foam cell formation, a hallmark of early atherosclerosis, in the presence of low-density lipoprotein (LDL). This study examined the role that Toll-like receptor 2 (TLR2) and TLR4 may play in pathogen-induced foam cell formation. Murine macrophage RAW 264.7 cells either infected with C. pneumoniae or treated with the TLR4 ligand E. coli lipopolysaccharide (LPS) or the TLR2 ligand Pam 3 -Cys-Ala-Gly-OH (Pam) became Oil Red O-stained foam cells and showed increased cholesteryl ester (CE) content when cocultured with LDL. In macrophages from TLR2 −/− mice, foam cells were induced by Escherichia coli LPS but not by C. pneumoniae or Pam. Conversely, C. pneumoniae or Pam, but not E. coli LPS, induced foam cells in the TLR4-deficient GG2EE macrophage cell line, suggesting that C. pneumoniae elicits foam cell formation predominantly via TLR2. Enhancing cholesterol efflux using the liver X receptor (LXR) agonist GW3965 significantly decreased the CE content of cells exposed to each of the three TLR ligands ( C. pneumoniae , Pam, and E. coli LPS). Overall, our results suggest that activation of the LXR signaling pathway may affect potentially atherogenic processes modulated by the TLR ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019 · cited 2×
“A role for TLR4 in modulating atherosclerosis has also been proposed (32).”
BackgroundControl of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
Self-citationCD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873 · cited 1×
“The recent discovery of CD36 as a coreceptor for TLR2 raises the prospect that a novel proinflammatory pathway exists between endogenously derived lipids and activation of innate immunity (17).”
BackgroundVabulas, R. M., Ahmad-Nejad, P., da Costa, C., Miethke, T., Kirschning, C. J., Häcker, H., & Wagner, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103217200 · Cited by 805 · cited 2×
“TLR4 (7, 26, 37, 39, 47), although TLR2 seems to play the”
BackgroundBjörkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634 · cited 1×
“Animal studies (2, 18, 32) have shown that the loss of TLR4 or myeloid differentiation factor 88 (MyD88), the common TLR signaling adaptor molecule, reduces disease severity in atherosclerosis-prone, apolipoprotein E-deficient (apoE / ) mice (32).”
BackgroundModulation of atherosclerosis in mice by Toll-like receptor 2
Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549 · cited 2×
“Loss of TLR2 was reported to result in decreased atherosclerotic lesion size, whereas systemic exposure to a TLR2 ligand was found to dramatically increase lesion severity (36), establishing a clear role for TLR2 in modulating the severity of experimental atherosclerosis in mice.”
Background
Cited by
Are Reactive Oxygen Species Always Detrimental to Pathogens?
Paiva, C. N., & Bozza, M. T. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5447 · Cited by 564
Innate immunity, macrophage activation, and atherosclerosis
Yan, Z., & Hansson, G. K. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00554.x · Cited by 256
The Expression and Functions of Toll-Like Receptors in Atherosclerosis
Cole, J. E., Georgiou, E., & Monaco, C. (2010) · Mediators of Inflammation · doi:10.1155/2010/393946 · Cited by 177
“[136] F.”
BackgroundLipid Bodies in Inflammatory Cells: Structure, Function, and Current Imaging Techniques
Melo, R. C. N., D’Avila, H., Wan, H.-C., Bozza, P. T., Dvorak, A. M., & Weller, P. F. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411404073 · Cited by 163
“(Cao et al., 2007; D’Avila et al. 2006; Mattos et al., 2010, 2011; Pacheco et al., 2002; Peyron et al., 2008) Mycobacterium smegmatis − − − n.”
Melo, R. C. N., & Dvorak, A. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002729 · Cited by 139
Metadata
- Authors
- Cao, F., Castrillo, A., Tontonoz, P., Re, F., & Byrne, G. I.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 75
- Issue
- 2
- Pages
- 753-759
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2105682847
- Cited by
- 145
- References
- 8
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.